Uploads
Contact
/
Login
Upload
Search Results for 'Magellan Primary Efficacy Endpoint At 10 Days Dvt Symptomatic Pe'
Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers by Andexanet Alfa
lois-ondreau
Laquinimod
luanne-stotts
A New Era for NOACs: Program Goals
danika-pritchard
Dabigatran in myocardial injury after noncardiac
lois-ondreau
Watchman I: First Report of the 5-Year PROTECT-AF and Exten
debby-jeon
Rivaroxaban compared with enoxaparin for the prevention of
luanne-stotts
THERAPY Trial
celsa-spraggs
ISCB Vaccines Sub-Committee Web Seminar Series
danika-pritchard
Magellan f/5 Planning and Status
jane-oiler
Magellan f/5 Planning and Status
jane-oiler
Was Magellan Worth Defending?
karlyn-bohler
Was Magellan Worth Defending?
aaron
Ferdinand Magellan
kittie-lecroy
Ferdinand Magellan
pamella-moone
New Treatments for CTEPH
faustina-dinatale
Innovative Features of the ADAPTABLE Trial
debby-jeon
Two-Year Outcomes of
jane-oiler
What's New in Atopic Dermatitis
cheryl-pisano
Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial
natalia-silvester
On-Treatment
lois-ondreau
‘EUROSTOMY’
kittie-lecroy
Who Benefited Most From Immediate Treatment in START
lois-ondreau
Oral Antiplatelet Therapy in ACS
kittie-lecroy
Efficacy of initial combination
natalia-silvester
1
2
3
4
5
6